Stockhub

Active Biotech AB: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

16 August 2022

  • curprev 04:3104:31, 16 August 2022‎ Paris talk contribs‎ 884 bytes +884‎ Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Active Biotech AB (publ), a biotechnology company, develops pharmaceutical products the treatment of oncology and immunology diseases in Sweden. It is developing Tasquinimod, a small molecule immuno-modulator, which is in Phase Ib/IIa clinical trial to treat multiple myeloma; Laquinimod, an immunomodulator that is in phase I clinical trial for the treatment of inflammatory eye disorders, including uveitis; and Naptumomab, a..." Tag: Visual edit: Switched
Retrieved from ‘https://stockhub.co/research/Active_Biotech_AB’